I'm LongbridgeAI, I can summarize articles.Protagonist Therapeutics granted inducement equity awards to two new hires on Aug. 17, 2026. The package includes options for 5,675 shares and RSUs for 1,500 shares at a $155.1 strike price. Options vest over four years with 25% after one year, while RSUs vest 25% annually.
- Protagonist Therapeutics granted inducement equity awards on Aug. 17, 2026 to two newly hired employees. * Awards covered options for 5,675 shares, RSUs for 1,500 shares under its amended and restated inducement plan. * Options carry an exercise price of $155.1, matching the Aug. 17 Nasdaq closing price. * Option vesting runs four years: 25% after one year, balance monthly over the next three years. * RSUs vest 25% annually over four years. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagonist Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608181605ACCESSWRNAPR_____1208880) on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)